STAT1 |
K562 (myelogenous leukemia) |
Interferon gamma treatment - 6 hours (Snyder) |
Permissive
Robust
|
Homo sapiens |
ENCSR000EHJ
|
MA0137.3
|
STAT1 |
K562 (myelogenous leukemia) |
Interferon gamma treatment - 30 minutes (Snyder) |
Permissive
Robust
|
Homo sapiens |
ENCSR000EHK
|
MA0137.3
|
STAT1 |
K562 (myelogenous leukemia) |
Interferon alpha treatment - 6 hours (Snyder) |
Permissive
Robust
|
Homo sapiens |
ENCSR000FAU
|
MA0137.3
|
STAT1 |
K562 (myelogenous leukemia) |
30 m of Interferon alpha (Snyder) |
Permissive
Robust
|
Homo sapiens |
ENCSR000FAV
|
MA0137.3
|
STAT1 |
T-cells |
IFNg |
Permissive
|
Homo sapiens |
GSE27158
...
|
MA0137.3
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNγ for 6 hour |
Permissive
Robust
|
Mus musculus |
GSE33913
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNβ for 6 hour |
Permissive
Robust
|
Mus musculus |
GSE33913
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNγ for 6 hour |
Permissive
Robust
|
Mus musculus |
GSE33913
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNβ for 6 hour |
Permissive
Robust
|
Mus musculus |
GSE33913
...
|
MA0137.3
...
|
STAT1 |
HeLa S3 (cervical adenocarcinoma) |
IFN gamma |
Permissive
Robust
|
Homo sapiens |
GSE12782
...
|
MA0137.3
...
|
STAT1 |
HeLa S3 (cervical adenocarcinoma) |
IFNgamma |
Permissive
Robust
|
Homo sapiens |
GSE15353
...
|
MA0137.3
...
|
STAT1 |
dendritic cells |
LPS, 0 min |
Permissive
|
Mus musculus |
GSE36099
...
|
MA0137.3
...
|
STAT1 |
dendritic cells |
LPS, 120 min |
Permissive
|
Mus musculus |
GSE36099
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNg (100 ng/ml) for 30min |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNg (100 ng/ml) for 1hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNg (100 ng/ml) for 2hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNg (100 ng/ml) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE38377
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNbeta for 30 minutes |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNbeta for 60 minutes |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNbeta for 30 minutes |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNbeta for 60 minutes |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
LPS 10ng/ml for 2 hours |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNbeta 100U/ml for 1 hour |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNbeta 100U/ml for 2 hour |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNbeta 100U/ml for 4 hour |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNbeta 100U/ml for 1 hour |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNbeta 100U/ml for 2 hour |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNbeta 100U/ml for 4 hour |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNgamma 100U/ml for 1 hour |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNgamma 100U/ml for 2 hour |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNgamma 100U/ml for 4 hour |
Permissive
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNgamma 100U/ml for 1 hour |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNgamma 100U/ml for 2 hour |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
IFNgamma 100U/ml for 4 hour |
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
CD4+ T-cells |
IL21 |
Permissive
|
Mus musculus |
GSE63204
...
|
MA0137.3
...
|
STAT1 |
CD4+ T-cells |
Stat3 KO |
Permissive
|
Mus musculus |
GSE63204
...
|
MA0137.3
...
|
STAT1 |
CD4+ T-cells |
Stat3 KO, IL21 |
Permissive
|
Mus musculus |
GSE63204
...
|
MA0137.3
...
|
STAT1 |
CD4+ T-cells |
3 day in vitro culture for Th0 |
Permissive
|
Mus musculus |
GSE65621
...
|
MA0137.3
|
STAT1 |
CD4+ T-cells |
3 day in vitro culture for Th0, treatment (IL6) |
Permissive
|
Mus musculus |
GSE65621
...
|
MA0137.3
...
|
STAT1 |
CD4+ T-cells |
3 day in vitro culture for Th0, treatment (IL27) |
Permissive
|
Mus musculus |
GSE65621
...
|
MA0137.3
...
|
STAT1 |
CD4+ T-cells |
3 day in vitro culture for Th0, STAT3 KO |
Permissive
|
Mus musculus |
GSE65621
...
|
MA0137.3
...
|
STAT1 |
CD4+ T-cells |
3 day in vitro culture for Th0, treatment (IL6), STAT3 KO |
Permissive
|
Mus musculus |
GSE65621
...
|
MA0137.3
...
|
STAT1 |
CD4+ T-cells |
3 day in vitro culture for Th0, treatment (IL27), STAT3 KO |
Permissive
|
Mus musculus |
GSE65621
...
|
MA0137.3
...
|
STAT1 |
B-cells |
10,000U IFNa |
Permissive
|
Mus musculus |
GSE75250
...
|
MA0137.3
...
|
STAT1 |
bone marrow-derived macrophages |
IFNg 2h |
Permissive
Robust
|
Mus musculus |
GSE84518
...
|
MA0137.3
...
|
STAT1 |
bone marrow-derived macrophages |
IFNg IL4 2h |
Permissive
Robust
|
Mus musculus |
GSE84518
...
|
MA0137.3
...
|
STAT1 |
bone marrow-derived macrophages |
IFNg (100 ng/ml) for 2hrs |
Permissive
Robust
|
Mus musculus |
GSE84518
...
|
MA0137.3
...
|
STAT1 |
bone marrow-derived macrophages |
IFNg (100 ng/ml) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE84518
...
|
MA0137.3
...
|
STAT1 |
AT-3 (mammary tumor) |
DMSO vehicle |
Permissive
|
Mus musculus |
GSE94130
...
|
MA0137.3
...
|
STAT1 |
AT-3 (mammary tumor) |
1000nM JQ1 |
Permissive
|
Mus musculus |
GSE94130
...
|
MA0137.3
...
|
STAT1 |
AT-3 (mammary tumor) |
1ng/mL IFN-γ |
Permissive
|
Mus musculus |
GSE94130
...
|
MA0137.3
...
|
STAT1 |
AT-3 (mammary tumor) |
1000nM JQ1+ 1ng/mL IFN-γ |
Permissive
|
Mus musculus |
GSE94130
...
|
MA0137.3
...
|
STAT1 |
CD4+ T-cells |
ChIP-seq in vitro culture protocol (IFN-β) |
Permissive
|
Mus musculus |
GSE96724
...
|
MA0137.3
...
|
STAT1 |
CD4+ T-cells |
ChIP-seq in vitro culture protocol (IFN-γ) |
Permissive
|
Mus musculus |
GSE96724
...
|
MA0137.3
...
|
STAT1 |
CD4+ T-cells |
ChIP-seq in vitro culture protocol (nc) |
Permissive
|
Mus musculus |
GSE96724
...
|
MA0137.3
|
STAT1 |
CD4+ T-cells |
ChIP-seq in vitro culture protocol (IFN-β) |
Permissive
|
Mus musculus |
GSE96724
...
|
MA0137.3
...
|
STAT1 |
CD4+ T-cells |
ChIP-seq in vitro culture protocol (IFN-γ) |
Permissive
|
Mus musculus |
GSE96724
...
|
MA0137.3
...
|
STAT1 |
CD4+ T-cells |
ChIP-seq in vitro culture protocol (nc) |
Permissive
|
Mus musculus |
GSE96724
...
|
MA0137.3
...
|
STAT1 |
HPC7 (haematopoietic multipotent progenitors) |
serum-starved |
Permissive
|
Mus musculus |
GSE100835
...
|
MA0137.3
...
|
STAT1 |
HPC7 (haematopoietic multipotent progenitors) |
thrombopoietin 30 minutes |
Permissive
Robust
|
Mus musculus |
GSE100835
...
|
MA0137.3
...
|
STAT1 |
primary splenic NK cells |
IFNa |
Permissive
|
Mus musculus |
GSE106137
...
|
MA0137.3
...
|
STAT1 |
primary splenic NK cells |
IFNa, IL2 |
Permissive
Robust
|
Mus musculus |
GSE106137
...
|
MA0137.3
...
|
STAT1 |
SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens) |
Treatment: DMSO 0.1%; Cell type: essential thrombocythemia; |
Permissive
|
Homo sapiens |
GSE100566
...
|
MA0137.3
...
|
STAT1 |
SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens) |
Treatment: DMSO 0.1%; Cell type: essential thrombocythemia; |
Permissive
|
Homo sapiens |
GSE100566
...
|
MA0137.3
...
|
STAT1 |
SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens) |
Treatment: CA 25 nM; Cell type: essential thrombocythemia; |
Permissive
|
Homo sapiens |
GSE100566
...
|
MA0137.3
...
|
STAT1 |
SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens) |
Treatment: CA 25 nM; Cell type: essential thrombocythemia; |
Permissive
|
Homo sapiens |
GSE100566
...
|
MA0137.3
...
|
STAT1 |
SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens) |
Treatment: untreated; Cell type: essential thrombocythemia; |
Permissive
|
Homo sapiens |
GSE100566
...
|
MA0137.3
...
|
STAT1 |
SET2 (Adult acute megakaryoblastic leukemia, Homo Sapiens) |
Treatment: untreated; Cell type: essential thrombocythemia; |
Permissive
|
Homo sapiens |
GSE100566
...
|
MA0137.3
...
|
STAT1 |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
|
Homo sapiens |
ENCSR332EYT
|
MA0137.3
|
STAT1 |
GM23338 |
|
Permissive
|
Homo sapiens |
ENCSR071NFQ
|
MA0137.3
...
|
STAT1 |
T-cells |
|
Permissive
|
Homo sapiens |
GSE27158
...
|
MA0137.3
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
Robust
|
Mus musculus |
GSE33913
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
Robust
|
Mus musculus |
GSE33913
...
|
MA0137.3
...
|
STAT1 |
HeLa S3 (cervical adenocarcinoma) |
|
Permissive
|
Homo sapiens |
GSE15353
...
|
MA0137.3
|
STAT1 |
CD4+ T-cells |
|
Permissive
|
Mus musculus |
GSE40463
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
|
Mus musculus |
GSE38377
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
|
Mus musculus |
GSE38377
...
|
MA0137.3
...
|
STAT1 |
CD4+ T-cells |
|
Permissive
|
Mus musculus |
GSE51531
...
|
MA0517.1
|
STAT1 |
3T3-L1 (embryonic fibroblasts) |
|
Permissive
|
Mus musculus |
GSE56872
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
Robust
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
|
Mus musculus |
GSE56121
...
|
MA0137.3
...
|
STAT1 |
CD4+ T-cells |
|
Permissive
|
Mus musculus |
GSE63204
...
|
MA0137.3
...
|
STAT1 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
|
Homo sapiens |
GSE81859
...
|
MA0137.3
...
|
STAT1 |
bone marrow-derived macrophages |
|
Permissive
Robust
|
Mus musculus |
GSE84518
...
|
MA0137.3
...
|
STAT1 |
NCI-H358 (human nnon small cell lung cancer cell line) |
|
Permissive
|
Homo sapiens |
GSE79707
...
|
MA0517.1
|
STAT1 |
AGS (gastric adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE79707
...
|
MA0137.3
...
|
STAT1 |
|
INFG_LPS |
Permissive
|
Homo sapiens |
GSE43036
|
MA0137.3
|
STAT1 |
|
LPS |
Permissive
|
Homo sapiens |
GSE43036
|
MA0137.3
|